Alnylam Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ALNY Nasdaq 2830 www.alnylam.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Alnylam Pharmaceuticals, Inc.

Is It Time To Reassess Alnylam (ALNY) After Recent Share Price Pullback? - Jan 14th, 2026 7:07 am
JPM26: 2025 a “breakout year” for rare disease biotechs - Jan 14th, 2026 6:02 am
A Look At Alnylam Pharmaceuticals (ALNY) Valuation After Unveiling Its Alnylam 2030 Growth Plan - Jan 13th, 2026 11:11 pm
Alnylam Pharmaceuticals (ALNY) Is Down 9.0% After Ambitious 2026 Guidance And 2030 Plan Reveal - Jan 13th, 2026 4:30 pm
Alnylam Pharmaceuticals CEO on Development Goals, Profitability - Jan 12th, 2026 5:03 pm
JPM Preannouncements: Why Alnylam And Sarepta Lost, But Day One Won - Jan 12th, 2026 2:18 pm
Adimab Reports Strong Partnering Year for 2025 - Jan 12th, 2026 12:57 pm
Alnylam Pharmaceuticals Unveils “Alnylam 2030” as Amvuttra Drives Breakout Growth at JPMorgan Conf. - Jan 12th, 2026 12:42 pm
AbbVie buys into PD-1/VEGF sweepstakes; Alnylam and Vertex set expectations - Jan 12th, 2026 4:24 am
Alnylam Launches "Alnylam 2030" Strategy to Drive Next Era of Growth and Patient Impact - Jan 11th, 2026 3:00 pm
Is Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) 19% ROE Better Than Average? - Jan 11th, 2026 7:00 am
Healthcare dealmakers head to San Francisco hoping for megamergers in 2026 - Jan 9th, 2026 9:19 am
Biotech Stocks' Dark Winter Is Over. What That Means For Investors. - Jan 8th, 2026 6:00 am
Alnylam Pharmaceuticals (NASDAQ:ALNY) Seems To Use Debt Quite Sensibly - Jan 7th, 2026 6:00 am
Scenic Biotech Enters License and Research Agreement with Ono Pharmaceutical - Jan 7th, 2026 3:00 am
Alnylam to Webcast Presentation at 44th Annual J.P. Morgan Healthcare Conference - Jan 5th, 2026 7:15 am
What PeptiDream (TSE:4587)'s New Oral IL-17 Program and RNAi Milestone Mean For Shareholders - Dec 20th, 2025 5:10 am
Here’s Why Alnylam Pharmaceuticals (ALNY) Surged in Q3 - Dec 19th, 2025 4:18 am
Alnylam’s Manufacturing Expansion and Extra-Hepatic RNAi Delivery Could Be A Game Changer For Alnylam Pharmaceuticals (ALNY) - Dec 18th, 2025 6:10 pm
Is It Too Late to Consider Alnylam After a 67.8% Surge in 2025? - Dec 18th, 2025 4:19 pm